US20090131978A1 - Defect occluder release assembly & method - Google Patents
Defect occluder release assembly & method Download PDFInfo
- Publication number
- US20090131978A1 US20090131978A1 US12/356,506 US35650609A US2009131978A1 US 20090131978 A1 US20090131978 A1 US 20090131978A1 US 35650609 A US35650609 A US 35650609A US 2009131978 A1 US2009131978 A1 US 2009131978A1
- Authority
- US
- United States
- Prior art keywords
- closure device
- snare
- defect
- occluder
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/32056—Surgical snare instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
Definitions
- the present invention generally relates to devices for occluding septal defects or shunts in the heart or the vascular system, and more particularly to a component of an interventional transcatheter delivery system for holding a defect occluder in a posture for reversible free-floating tethered deployment from a catheter for occluding a septal defect or the like, and an attendant method.
- tissue defect generally refers to a perforation or other type hole (i.e., a defect) which passes through a thin wall of muscle or other tissue (i.e., a septum) which divides or separates “areas” within the body.
- a perforation or other type hole i.e., a defect
- tissue i.e., a septum
- Such defects can occur, either congenitally or by acquisition, between chambers of the heart (i.e., atrium or ventricle) or the great vessels (interatrial and interventricular septal defects or patent ductus arteriosus and aortico-pulminatry window respectively), causing shunting of blood through the opening.
- Atrial septal defects were initially corrected by open heart surgery which required the surgeon to open the chest of a patient and bypass the heart temporarily (e.g., by means of a mechanical heart or a “heart-lung machine”). The surgeon would then physically cut into the heart and suture small defects closed. In the case of larger defects, a patch of a biologically compatible material would be sewn onto the septum to cover (i.e., “patch”) the defect. Balloon catheters, similar to that disclosed by Landymore et al. in U.S. Pat. No. 4,836,204, have been used by physicians to temporarily occlude septal defects, as a stabilizing measure, prior to implementation of corrective open heart surgical techniques.
- an occluding device is delivered through a catheter to the septal defect site. Once the closure device is positioned adjacent the defect, it must be attached to the rest of the septum in a manner which permits it to effectively block the passage of blood through the defect.
- U.S. Pat. No. 3,874,388 (King et al.), includes a pair of complex mechanical umbrellas, each having a plurality of arms extending radially from a central hub.
- the hubs of the two umbrellas are mechanically connected to one another and each umbrella includes a fabric covering over the arms, much like a common umbrella.
- the ends of each arm are provided with barbs which are anchored into the septum to hold the occluder in place.
- the complex umbrellas prove rather difficult to unfold after passage through a catheter, requiring an array of cables to deploy the arms. This makes proper placement of the device difficult, and the barbs on the arms prevent retraction or repositioning of the device once it is in place.
- defect occluders do not optimally conform to the size (i.e., contour, dimensions and/or geometry) of the septal defect. Such devices therefore require great care in placement to ensure that the closure members entirely cover the defect. Because previously known devices typically use expanding frames to support the closure members that can straddle the opening of the defect, or otherwise become caught, complications may arise during implantation of such devices.
- Occluder systems generally have either a single “hard point” connection (i.e., the occluder is held for deployment by a substantially rigid “hard point” connection until final release thereof within a defect), or a dual point connection, namely a hard point connection in combination with a “soft” secondary release mechanism (e.g., a release cord or suture used to provide emergency retrieval post hard point release).
- a single hard point connection i.e., the occluder is held for deployment by a substantially rigid “hard point” connection until final release thereof within a defect
- a dual point connection namely a hard point connection in combination with a “soft” secondary release mechanism (e.g., a release cord or suture used to provide emergency retrieval post hard point release).
- a single hard point connection i.e., the occluder is held for deployment by a substantially rigid “hard point” connection until final release thereof within a defect
- a dual point connection namely a hard point connection in combination with a “soft” secondary release
- the Amplatzer® and ASDOS single hard point systems push the occluder from the catheter into the defect using an externally threaded rod (i.e., torquer catheter) that mates with a threaded nut, or the like, integral to the occluder, with release of the device thereafter once the occluder is adequately seated in the defect.
- an externally threaded rod i.e., torquer catheter
- torquer catheter i.e., torquer catheter
- the dual point connection which specifically addressed the shortcomings of the single hard point connection, provides a mechanism by which the occluder may be emergently retrieved in the case of mis-deployment after hard point release.
- the dual point CardioSEAL and HELEX systems permit the physician to better observe the occluder in a more “natural” condition or state, having previously disengaged the occluder from the single hard point connection, thereby effectively minimizing potential cardiac distortion.
- no effective repositioning may be effectuated once the hard point connection has been disengaged without fear of damaging the occluder and thereby causing malfunction: only retrieval is possible should mis-deployment of the occluder be suspected.
- a further disadvantage to this method of occluder attachment is that occluder redeployment is not possible: having disengaged the hard point “control” connection, redeployment, in addition to repositioning, is no longer possible, with occluder retrieval via the soft point connection typically destroying the device.
- the soft point attachment is generally released by cutting the suture or cord at the rear of the delivery system, and drawing the full length of the suture from the occluder and through the entire delivery system—a procedure which effectively opens a fluid pathway from the rear of the delivery system into the area of the defect, especially of concern when occluding an atrial or ventricle defect, thereby creating attendant risks with such release arrangement and procedure.
- defect occluder system capable of reversibly retaining an occluder so as to be observable in its final position prior to release. More particularly, it is highly desirable to provide a delivery system release assembly which allows the device to free float in the defect, while maintaining the ability to reposition and or retrieve it, at any time prior to final release, without implicating occluder integrity. Further still, it is desirable to provide in a defect occluder delivery system a soft occluder release accomplished with reduced attendant patient risk, such as the elimination of problems associated with opening the fluid pathway from the rear of the delivery system into the heart.
- a release assembly is provided to aid the reversible and repositionable deployment of a defect occluder.
- the release assembly includes an occluder tether having a distal portion comprising at least one suture loop, and a snare structure having a distal portion comprising a snare element.
- the at least one suture loop is receivable through at least a portion of the defect occluder, and reversibly looped over an anchor element so as to permit reversible collapse the defect occluder for selective ingress and egress from a delivery catheter.
- the snare element is reversibly engageable with the anchor element so as to reversibly retain the at least one suture loop upon the anchor element, and thereby hold the defect occluder in a posture for reversible free-floating tethered deployment in a defect while being observable in a final position prior to release.
- FIG. 1 is a side elevational view of a deployed septal defect occluder tethered to the release assembly of the present invention, shown in a sectional side view, with parts broken away to show underlying detail; and,
- FIG. 2 is a detailed view of area shown in FIG. 1 , illustrating the pin wire and snare structure of the present invention, particularly showing retention of suture loops on the pin wire, and the occluder thereby, by a snare loop.
- Release assemblies are generally considered to be a component of an occluder delivery system, such systems being typically characterized as including a delivery catheter for containing or housing an occluder pre-deployment, and a “pusher tube,” having at least one lumen for receiving an occluder control mechanism, for moving the occluder through the delivery catheter to the septal defect.
- a delivery catheter for containing or housing an occluder pre-deployment
- a pushher tube having at least one lumen for receiving an occluder control mechanism, for moving the occluder through the delivery catheter to the septal defect.
- a septal defect closure device 8 is shown in a reversible free-floating tethered deployment relative a septum S (e.g., an atrial septum) so as to effectively conform and block a defect, thereby preventing the flow of blood through the atrial septum to the adjoining chambers.
- the septal defect closure device need not be of the style shown, or any particular or preferred style, as all are readily deployable, or at a minimum easily adapted for deployment by those of skill in the art, using the release assembly of the subject invention.
- the release assembly 10 of the present invention generally includes an occluder tether 12 , an anchor element 14 , and a snare structure 16 , each of which being receivable in the lumens 18 of a multi-lumen pushing tube 20 which is disposed within a delivery catheter 22 .
- the occluder tether 12 reversibly extendible from a distal end of a first lumen, generally has proximal 24 and distal 26 portions, the distal portion 26 (i.e., component nearest the occluder 8 ) comprising at least one suture loop 28 receivable through at least a portion of the occluder 8 .
- the at least one suture loop 28 is reversibly looped over the anchor element 14 so as to permit reversible collapse of the occluder 8 for selective ingress and egress from the delivery catheter 22 .
- the snare structure 16 which is extendible from a distal end of a second lumen, has a distal portion comprising a snare element 32 .
- the snare element 32 is received by, or otherwise cooperatively engaged with/to, the anchor element 14 , which may be disposed within its own lumen (i.e., third lumen, not shown), or within the second lumen, as shown in FIG. 1 , so as to reversibly retain (e.g., by obstructing) the at least one suture loop 28 upon the anchor element 14 .
- the snare element 32 effectively “holds” the defect occluder 8 in a posture for reversible free-floating tethered deployment in a defect while being observable in a final position prior to release.
- the occluder tether 12 is shown having two suture loops 28 , the number of suture loops being dictated by application specific variables (e.g., nature of the defect, style of selected occluder, etc.).
- the at least one suture loop 28 is receivable through, or otherwise arranged to cooperate with, portions of the occluder 8 for manipulation during deployment.
- the dual suture loops 28 are shown received in (i.e. threaded through) eyelets 9 of an occluder 8 .
- the “free” ends 24 of the dual loops 28 i.e., loop crotches) are reversibly received about the anchor element 14 to controlingly hold the occluder 8 .
- the occluder tether 12 may be of unitary or composite construction or composition.
- the proximal portion 24 of the occluder tether 12 may be constructed of nitinol, or of any type of metal or plastic that demonstrates good flexibility and kink resistance, whereas the distal portion 26 , more particularly the suture loops 28 themselves, may be constructed of stranded nitinol, stranded polyester, straight nitinol, spring temper stainless steel, braided silk, braided polyester, braided nylon, or polyester or nylon monofilament, or any other material that demonstrates good kink resistance, flexibility, and low stretch.
- the tether portions 24 and 26 may be discrete elements, joined as will be later discussed with respect to the snare structure 16 , it is only necessary that the suture loops 28 extend from the proximal portion 24 of the tether 12 such that the tether structure 12 possesses sufficient tensile strength for occluder manipulation and retrieval.
- the snare structure 16 like the occluder tether 12 , has proximal 34 and distal 36 portions, and may be of unitary or composite construction or composition.
- the proximal portion 34 may be made of nitinol, or of any type of material that demonstrates good flexibility and kink resistance.
- the snare element 32 is preferably a loop, although functional equivalents and alternatives to the snare loop are contemplated, and include, but are not limited to, balls, disks, or other structures that retain the suture loops 28 on the anchor element 14 (i.e., keep the suture loops 28 from inadvertent or unintended release) prior to selective release of the occluder.
- the snare element 32 may be made of stranded nitinol, straight nitinol, braided polyester, braided nylon, braided silk, polyester or nylon monofilament, or any other material that demonstrates good kink resistance and flexibility.
- the snare structure portions 34 and 36 are indicated as being united discrete elements.
- the snare loop 32 has an end thereof received in/at an end of the proximal portion 34 of the snare structure 16 (i.e., the distal end surface thereof), the interface of the proximal 34 and distal 36 portions of the snare structure 16 being characterized by a crimp 38 which secures the portions 34 and 36 to each other, and thereby forms a unitary snare structure 16 .
- Other known methods of joining the snare structure portions 34 and 36 are contemplated, in addition to an integral fabrication of the snare structure 16 (e.g., unitary construction).
- the snare element 32 is preferably welded on the end of the proximal portion 34 of the snare structure 16 , and is constructed of identical, or at least compatible, construction materials.
- the snare element 32 is preferably welded, crimped or otherwise affixed onto the end of the proximal portion 34 of the snare structure 16 , but may be attached by any method that provides sufficient tensile strength for retaining the suture loops 28 upon the anchor element 14 .
- the material of the disk may be any material that has structural rigidity and is readily affixable to the material of the proximal portion 34 of the snare structure 16 .
- the anchor element 14 is preferably a pin wire.
- the pin wire may be made of nitinol, or of any type of metal or plastic that demonstrates a combination of good flexibility to avoid excessive stiffening of the catheter, and structural strength to prevent premature suture loop release caused by wire buckling.
- the pin wire 14 receives the suture loops 28 and the snare element 32 so as to anchor the occluder during deployment, placement, and adjustment procedures.
- the preferred configuration of the release assembly 10 is to pass the occluder tether 12 through one lumen 18 of a double lumen pusher tube 20 , and pass both the snare structure 16 and the anchor element 14 through the other lumen of the same pusher tube 20 .
- the double lumen tubing 20 is sized such that it fits inside the lumen of the outer catheter 22 of the delivery system.
- the suture loops 28 are passed through the eyelets 9 , or equivalent tether receiving structure(s), of the occluder 8 , and the loop ends 29 are hooked over the free end of the pin wire 14 .
- the loop 32 of the snare structure 16 is then hooked over the pin wire 14 , distal to the suture loops 28 , with the pin wire 14 advanceable in relation to the snare loop 32 in order to prevent the snare loop 32 from sliding off the pin wire 14 .
- the pin wire 14 is retracted in relation to the snare loop 32 , thereby liberating the suture loops 28 from the pin wire 14 .
- retraction of the occluder tether 12 in relation to the occluder 8 , draws the suture loops 28 out of the eyelets 9 of the occluder 8 , thereby releasing the device.
- the proximal portion of the tether is approximately 0.029′′ diameter nitinol wire of approximately 47.25′′ (120 centimeters) in length.
- a hole or crater is present in the end (i.e., the distal end surface of the proximal tether portion) that is about 0.100′′ deep and approximately 0.017′′ in diameter. This hole receives the ends of the two suture loops that are crimped into place, the suture loops being constructed of stranded nitinol wire with a diameter of approximately 0.006′′.
- the suture loops are of a length sufficient to be threaded through the eyelets of an occluder so that the device is allowed to rest in a fully deployed position while the suture loops remain substantially slack (i.e., permit free-floating deployment of the occluder into the defect).
- the proximal portion of the snare structure is a nitinol wire having a diameter of about 0.029′′ and a length of approximately 47.25′′Like the tether construction, the distal end surface of the proximal portion of the snare structure has a hole or dimple dimensioned to be about 0.100′′ deep and approximately 0.017′′ in diameter. This hole receives the end of the snare loop, which is ultimately crimped into place.
- the snare loop is made of nitinol stranded wire having a diameter of approximately 0.006′′The length of stranded wire is approximately 0.400′′, which when crimped provides a loop of approximately 0.100′′ in length.
- the pin wire preferably is a nitinol wire having a diameter of approximately 0.017′′ and a length of approximately 47.25′′.
Abstract
Description
- The present application is a continuation of U.S. application Ser. No. 10/227,773, filed Aug. 26, 2002, now U.S. Pat. No. 7,479,155, which is a continuation of U.S. application Ser. No. 09/628,211, filed Jul. 28, 2000, now U.S. Pat. No. 6,440,152, both of which are incorporated by reference herein.
- The present invention generally relates to devices for occluding septal defects or shunts in the heart or the vascular system, and more particularly to a component of an interventional transcatheter delivery system for holding a defect occluder in a posture for reversible free-floating tethered deployment from a catheter for occluding a septal defect or the like, and an attendant method.
- The term “septal defect” generally refers to a perforation or other type hole (i.e., a defect) which passes through a thin wall of muscle or other tissue (i.e., a septum) which divides or separates “areas” within the body. Such defects can occur, either congenitally or by acquisition, between chambers of the heart (i.e., atrium or ventricle) or the great vessels (interatrial and interventricular septal defects or patent ductus arteriosus and aortico-pulminatry window respectively), causing shunting of blood through the opening.
- Atrial septal defects were initially corrected by open heart surgery which required the surgeon to open the chest of a patient and bypass the heart temporarily (e.g., by means of a mechanical heart or a “heart-lung machine”). The surgeon would then physically cut into the heart and suture small defects closed. In the case of larger defects, a patch of a biologically compatible material would be sewn onto the septum to cover (i.e., “patch”) the defect. Balloon catheters, similar to that disclosed by Landymore et al. in U.S. Pat. No. 4,836,204, have been used by physicians to temporarily occlude septal defects, as a stabilizing measure, prior to implementation of corrective open heart surgical techniques.
- To overcome limitations of surgical closure, a variety of interventional transcatheter closure techniques have been attempted. In such techniques, an occluding device is delivered through a catheter to the septal defect site. Once the closure device is positioned adjacent the defect, it must be attached to the rest of the septum in a manner which permits it to effectively block the passage of blood through the defect.
- One such early closure device, U.S. Pat. No. 3,874,388 (King et al.), includes a pair of complex mechanical umbrellas, each having a plurality of arms extending radially from a central hub. The hubs of the two umbrellas are mechanically connected to one another and each umbrella includes a fabric covering over the arms, much like a common umbrella. The ends of each arm are provided with barbs which are anchored into the septum to hold the occluder in place. The complex umbrellas prove rather difficult to unfold after passage through a catheter, requiring an array of cables to deploy the arms. This makes proper placement of the device difficult, and the barbs on the arms prevent retraction or repositioning of the device once it is in place.
- Although much progress has been made in the field since the King et al. device, heretofore known defect occluding systems, whether they be of a traditional atrial umbrella style (e.g., the ClamShell Septal Umbrella (ClamShell I, C. R. Bard, Inc.), the CardioSEAL device (Nitinol Medical Technologies, Inc.), the Sideris Buttoned Occluder (Sideris, U.S. Pat. No. 4,917,089), or the ASD Occlusion System (ASDOS, Dr. Osypka GmbH, Grenzach-Wyhlen, Germany), or other emerging plug style (e.g., The Monodisk System (Pavenik et al., U.S. Pat. No. 5,643,317), Angel Wings (Das, U.S. Pat. No. 5,578,045), the Amplatzer® Septal Occluder, or the HELEX Septal Occluder (W.L. Gore & Associates, Inc.), all suffer from a variety of common shortcomings.
- These, and other such devices, generally rely on the caudal and cranial ends of the device being larger than the opening of the defect itself to physically trap the device across the opening. To accommodate transcatheter delivery techniques, the resulting device configurations have become unduly mechanical in nature, often including multiple components (e.g., ASDOS) and/or requiring the sequential delivery of device components, as well as the use of loading jigs (e.g., ASDOS, CardioSEAL) to prepare the device for insertion. Furthermore, many of these devices require assembly across the defect post delivery (e.g., ASDOS), thereby increasing the complexity of the transcatheter equipment, and delivery process, as for instance, by requiring two separate catheter entry points (e.g., ASDOS).
- Further still, and of primary importance, heretofore known defect occluders do not optimally conform to the size (i.e., contour, dimensions and/or geometry) of the septal defect. Such devices therefore require great care in placement to ensure that the closure members entirely cover the defect. Because previously known devices typically use expanding frames to support the closure members that can straddle the opening of the defect, or otherwise become caught, complications may arise during implantation of such devices.
- Generally, a great deal of remote manipulation and repositioning is required for proper device deployment because heretofore known defect occluder systems hold or retain the occluder in such a way that the device cannot be observed in its final, fully expanded position within the defect until the device is completely released. Extensive remote manipulation, such as by applying tension to one or more cables in order to deploy the arms of an umbrella, for instance, or to anchor the device in place, not only increases the difficulty of the procedure, but tends to increase the likelihood that the device will be improperly deployed, or suffer material fatigue leading to device strut fracture, a fundamental and well documented problem of the aforementioned umbrella type devices. Further still, the likelihood of retrieval of such devices post deployment is great, and in some cases retrieval is required so as to effectively occlude the defect and minimize the risk of embolization.
- Occluder systems generally have either a single “hard point” connection (i.e., the occluder is held for deployment by a substantially rigid “hard point” connection until final release thereof within a defect), or a dual point connection, namely a hard point connection in combination with a “soft” secondary release mechanism (e.g., a release cord or suture used to provide emergency retrieval post hard point release). With the single hard point connection, a cyclical flexing of the occluder is possible therewith, however, once the hard point is disengaged from the occluder, further adjustment and retrieval is no longer possible.
- For example, the Amplatzer® and ASDOS single hard point systems push the occluder from the catheter into the defect using an externally threaded rod (i.e., torquer catheter) that mates with a threaded nut, or the like, integral to the occluder, with release of the device thereafter once the occluder is adequately seated in the defect. A major shortcoming of this method is that the position of the catheter tip in the heart in relation to the fully deployed occluder usually pulls the occluder into an unintended, and unnatural position. This distorts the septum of the heart, and the physician must trust that upon release of the occluder from the delivery system, the septum will return to a natural position and the occluder will adequately seal the defect. The single hard point connection does not permit the physician to observe the occluder as it would sit naturally in the heart until it is released.
- The dual point connection, which specifically addressed the shortcomings of the single hard point connection, provides a mechanism by which the occluder may be emergently retrieved in the case of mis-deployment after hard point release. The dual point CardioSEAL and HELEX systems permit the physician to better observe the occluder in a more “natural” condition or state, having previously disengaged the occluder from the single hard point connection, thereby effectively minimizing potential cardiac distortion. However, due to the nature of the soft point connection, no effective repositioning may be effectuated once the hard point connection has been disengaged without fear of damaging the occluder and thereby causing malfunction: only retrieval is possible should mis-deployment of the occluder be suspected. A further disadvantage to this method of occluder attachment is that occluder redeployment is not possible: having disengaged the hard point “control” connection, redeployment, in addition to repositioning, is no longer possible, with occluder retrieval via the soft point connection typically destroying the device. The soft point attachment is generally released by cutting the suture or cord at the rear of the delivery system, and drawing the full length of the suture from the occluder and through the entire delivery system—a procedure which effectively opens a fluid pathway from the rear of the delivery system into the area of the defect, especially of concern when occluding an atrial or ventricle defect, thereby creating attendant risks with such release arrangement and procedure.
- It is, therefore, advantageous to provide a defect occluder system capable of reversibly retaining an occluder so as to be observable in its final position prior to release. More particularly, it is highly desirable to provide a delivery system release assembly which allows the device to free float in the defect, while maintaining the ability to reposition and or retrieve it, at any time prior to final release, without implicating occluder integrity. Further still, it is desirable to provide in a defect occluder delivery system a soft occluder release accomplished with reduced attendant patient risk, such as the elimination of problems associated with opening the fluid pathway from the rear of the delivery system into the heart.
- A release assembly is provided to aid the reversible and repositionable deployment of a defect occluder. The release assembly includes an occluder tether having a distal portion comprising at least one suture loop, and a snare structure having a distal portion comprising a snare element. The at least one suture loop is receivable through at least a portion of the defect occluder, and reversibly looped over an anchor element so as to permit reversible collapse the defect occluder for selective ingress and egress from a delivery catheter. The snare element is reversibly engageable with the anchor element so as to reversibly retain the at least one suture loop upon the anchor element, and thereby hold the defect occluder in a posture for reversible free-floating tethered deployment in a defect while being observable in a final position prior to release.
- More specific features and advantages obtained in view of those features will become apparent with reference to the drawing figures and DETAILED DESCRIPTION OF THE INVENTION.
-
FIG. 1 is a side elevational view of a deployed septal defect occluder tethered to the release assembly of the present invention, shown in a sectional side view, with parts broken away to show underlying detail; and, -
FIG. 2 is a detailed view of area shown inFIG. 1 , illustrating the pin wire and snare structure of the present invention, particularly showing retention of suture loops on the pin wire, and the occluder thereby, by a snare loop. - Release assemblies are generally considered to be a component of an occluder delivery system, such systems being typically characterized as including a delivery catheter for containing or housing an occluder pre-deployment, and a “pusher tube,” having at least one lumen for receiving an occluder control mechanism, for moving the occluder through the delivery catheter to the septal defect. These, as well as other occluder delivery systems are described in the literature, and are well know to those of skill in the art.
- Referring to
FIG. 1 , a septal defect closure device 8 is shown in a reversible free-floating tethered deployment relative a septum S (e.g., an atrial septum) so as to effectively conform and block a defect, thereby preventing the flow of blood through the atrial septum to the adjoining chambers. The septal defect closure device need not be of the style shown, or any particular or preferred style, as all are readily deployable, or at a minimum easily adapted for deployment by those of skill in the art, using the release assembly of the subject invention. Therelease assembly 10 of the present invention generally includes anoccluder tether 12, ananchor element 14, and asnare structure 16, each of which being receivable in thelumens 18 of a multi-lumen pushingtube 20 which is disposed within adelivery catheter 22. A discussion of these elements, their components, and the interrelationships therebetween follows. - Referring now to
FIGS. 1 and 2 , theoccluder tether 12, reversibly extendible from a distal end of a first lumen, generally has proximal 24 and distal 26 portions, the distal portion 26 (i.e., component nearest the occluder 8) comprising at least onesuture loop 28 receivable through at least a portion of the occluder 8. The at least onesuture loop 28 is reversibly looped over theanchor element 14 so as to permit reversible collapse of the occluder 8 for selective ingress and egress from thedelivery catheter 22. Thesnare structure 16, which is extendible from a distal end of a second lumen, has a distal portion comprising asnare element 32. Thesnare element 32 is received by, or otherwise cooperatively engaged with/to, theanchor element 14, which may be disposed within its own lumen (i.e., third lumen, not shown), or within the second lumen, as shown inFIG. 1 , so as to reversibly retain (e.g., by obstructing) the at least onesuture loop 28 upon theanchor element 14. In this way thesnare element 32 effectively “holds” the defect occluder 8 in a posture for reversible free-floating tethered deployment in a defect while being observable in a final position prior to release. - In the embodiment illustrated, the
occluder tether 12 is shown having twosuture loops 28, the number of suture loops being dictated by application specific variables (e.g., nature of the defect, style of selected occluder, etc.). Generally, the at least onesuture loop 28 is receivable through, or otherwise arranged to cooperate with, portions of the occluder 8 for manipulation during deployment. InFIG. 1 , thedual suture loops 28 are shown received in (i.e. threaded through) eyelets 9 of an occluder 8. The “free” ends 24 of the dual loops 28 (i.e., loop crotches) are reversibly received about theanchor element 14 to controlingly hold the occluder 8. - The
occluder tether 12 may be of unitary or composite construction or composition. Theproximal portion 24 of theoccluder tether 12 may be constructed of nitinol, or of any type of metal or plastic that demonstrates good flexibility and kink resistance, whereas thedistal portion 26, more particularly thesuture loops 28 themselves, may be constructed of stranded nitinol, stranded polyester, straight nitinol, spring temper stainless steel, braided silk, braided polyester, braided nylon, or polyester or nylon monofilament, or any other material that demonstrates good kink resistance, flexibility, and low stretch. Although thetether portions snare structure 16, it is only necessary that thesuture loops 28 extend from theproximal portion 24 of thetether 12 such that thetether structure 12 possesses sufficient tensile strength for occluder manipulation and retrieval. - The
snare structure 16, like theoccluder tether 12, has proximal 34 and distal 36 portions, and may be of unitary or composite construction or composition. Theproximal portion 34 may be made of nitinol, or of any type of material that demonstrates good flexibility and kink resistance. As shown in the figures, thesnare element 32 is preferably a loop, although functional equivalents and alternatives to the snare loop are contemplated, and include, but are not limited to, balls, disks, or other structures that retain thesuture loops 28 on the anchor element 14 (i.e., keep thesuture loops 28 from inadvertent or unintended release) prior to selective release of the occluder. In the form of a loop, thesnare element 32 may be made of stranded nitinol, straight nitinol, braided polyester, braided nylon, braided silk, polyester or nylon monofilament, or any other material that demonstrates good kink resistance and flexibility. - With particular reference to
FIG. 2 , thesnare structure portions snare loop 32 has an end thereof received in/at an end of theproximal portion 34 of the snare structure 16 (i.e., the distal end surface thereof), the interface of the proximal 34 and distal 36 portions of thesnare structure 16 being characterized by acrimp 38 which secures theportions unitary snare structure 16. Other known methods of joining thesnare structure portions - In the form of a ball, the
snare element 32 is preferably welded on the end of theproximal portion 34 of thesnare structure 16, and is constructed of identical, or at least compatible, construction materials. In the form of a disk, thesnare element 32 is preferably welded, crimped or otherwise affixed onto the end of theproximal portion 34 of thesnare structure 16, but may be attached by any method that provides sufficient tensile strength for retaining thesuture loops 28 upon theanchor element 14. The material of the disk may be any material that has structural rigidity and is readily affixable to the material of theproximal portion 34 of thesnare structure 16. - The
anchor element 14 is preferably a pin wire. The pin wire may be made of nitinol, or of any type of metal or plastic that demonstrates a combination of good flexibility to avoid excessive stiffening of the catheter, and structural strength to prevent premature suture loop release caused by wire buckling. Thepin wire 14 receives thesuture loops 28 and thesnare element 32 so as to anchor the occluder during deployment, placement, and adjustment procedures. - The preferred configuration of the
release assembly 10 is to pass theoccluder tether 12 through onelumen 18 of a doublelumen pusher tube 20, and pass both thesnare structure 16 and theanchor element 14 through the other lumen of thesame pusher tube 20. Thedouble lumen tubing 20 is sized such that it fits inside the lumen of theouter catheter 22 of the delivery system. Thesuture loops 28 are passed through the eyelets 9, or equivalent tether receiving structure(s), of the occluder 8, and the loop ends 29 are hooked over the free end of thepin wire 14. Theloop 32 of thesnare structure 16 is then hooked over thepin wire 14, distal to thesuture loops 28, with thepin wire 14 advanceable in relation to thesnare loop 32 in order to prevent thesnare loop 32 from sliding off thepin wire 14. To release thesuture loops 28, thepin wire 14 is retracted in relation to thesnare loop 32, thereby liberating thesuture loops 28 from thepin wire 14. Thereafter, retraction of theoccluder tether 12, in relation to the occluder 8, draws thesuture loops 28 out of the eyelets 9 of the occluder 8, thereby releasing the device. - As to the preferred characteristics of the release assembly components, the proximal portion of the tether is approximately 0.029″ diameter nitinol wire of approximately 47.25″ (120 centimeters) in length. A hole or crater is present in the end (i.e., the distal end surface of the proximal tether portion) that is about 0.100″ deep and approximately 0.017″ in diameter. This hole receives the ends of the two suture loops that are crimped into place, the suture loops being constructed of stranded nitinol wire with a diameter of approximately 0.006″. The suture loops are of a length sufficient to be threaded through the eyelets of an occluder so that the device is allowed to rest in a fully deployed position while the suture loops remain substantially slack (i.e., permit free-floating deployment of the occluder into the defect).
- The proximal portion of the snare structure is a nitinol wire having a diameter of about 0.029″ and a length of approximately 47.25″Like the tether construction, the distal end surface of the proximal portion of the snare structure has a hole or dimple dimensioned to be about 0.100″ deep and approximately 0.017″ in diameter. This hole receives the end of the snare loop, which is ultimately crimped into place. The snare loop is made of nitinol stranded wire having a diameter of approximately 0.006″The length of stranded wire is approximately 0.400″, which when crimped provides a loop of approximately 0.100″ in length.
- The pin wire preferably is a nitinol wire having a diameter of approximately 0.017″ and a length of approximately 47.25″.
- While a preferred embodiment of the present invention has been described, it should be understood that various changes, adaptations and modifications may be made therein without departing from the spirit of the invention. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/356,506 US20090131978A1 (en) | 2000-07-28 | 2009-01-20 | Defect occluder release assembly & method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/628,211 US6440152B1 (en) | 2000-07-28 | 2000-07-28 | Defect occluder release assembly and method |
US10/227,773 US7479155B2 (en) | 2000-07-28 | 2002-08-26 | Defect occluder release assembly and method |
US12/356,506 US20090131978A1 (en) | 2000-07-28 | 2009-01-20 | Defect occluder release assembly & method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/227,773 Continuation US7479155B2 (en) | 2000-07-28 | 2002-08-26 | Defect occluder release assembly and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090131978A1 true US20090131978A1 (en) | 2009-05-21 |
Family
ID=24517940
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/628,211 Expired - Lifetime US6440152B1 (en) | 2000-07-28 | 2000-07-28 | Defect occluder release assembly and method |
US10/227,773 Expired - Fee Related US7479155B2 (en) | 2000-07-28 | 2002-08-26 | Defect occluder release assembly and method |
US12/356,506 Abandoned US20090131978A1 (en) | 2000-07-28 | 2009-01-20 | Defect occluder release assembly & method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/628,211 Expired - Lifetime US6440152B1 (en) | 2000-07-28 | 2000-07-28 | Defect occluder release assembly and method |
US10/227,773 Expired - Fee Related US7479155B2 (en) | 2000-07-28 | 2002-08-26 | Defect occluder release assembly and method |
Country Status (6)
Country | Link |
---|---|
US (3) | US6440152B1 (en) |
EP (2) | EP2158847A1 (en) |
JP (1) | JP2002119515A (en) |
CA (1) | CA2353333A1 (en) |
DE (1) | DE60140782D1 (en) |
ES (1) | ES2343401T3 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110071623A1 (en) * | 2006-11-07 | 2011-03-24 | Dc Devices, Inc. | Methods for deploying a prosthesis |
US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
US8882697B2 (en) | 2006-11-07 | 2014-11-11 | Dc Devices, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
US8951223B2 (en) | 2011-12-22 | 2015-02-10 | Dc Devices, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
US9005155B2 (en) | 2012-02-03 | 2015-04-14 | Dc Devices, Inc. | Devices and methods for treating heart failure |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US9277995B2 (en) | 2010-01-29 | 2016-03-08 | Corvia Medical, Inc. | Devices and methods for reducing venous pressure |
US9358371B2 (en) | 2006-11-07 | 2016-06-07 | Corvia Medical, Inc. | Intra-atrial implants made of non-braided material |
US9649480B2 (en) | 2012-07-06 | 2017-05-16 | Corvia Medical, Inc. | Devices and methods of treating or ameliorating diastolic heart failure through pulmonary valve intervention |
US9775636B2 (en) | 2013-03-12 | 2017-10-03 | Corvia Medical, Inc. | Devices, systems, and methods for treating heart failure |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
US10588611B2 (en) | 2012-04-19 | 2020-03-17 | Corvia Medical Inc. | Implant retention attachment and method of use |
Families Citing this family (174)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US7713282B2 (en) * | 1998-11-06 | 2010-05-11 | Atritech, Inc. | Detachable atrial appendage occlusion balloon |
EP1210014A1 (en) * | 1999-09-07 | 2002-06-05 | Microvena Corporation | Retrievable septal defect closure device |
US8083766B2 (en) | 1999-09-13 | 2011-12-27 | Rex Medical, Lp | Septal defect closure device |
US7662161B2 (en) | 1999-09-13 | 2010-02-16 | Rex Medical, L.P | Vascular hole closure device |
US6440152B1 (en) * | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US6702835B2 (en) * | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
WO2003022344A2 (en) * | 2001-09-06 | 2003-03-20 | Nmt Medical, Inc. | Flexible delivery system |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
EP1467661A4 (en) | 2001-12-19 | 2008-11-05 | Nmt Medical Inc | Septal occluder and associated methods |
AU2003220502A1 (en) | 2002-03-25 | 2003-10-13 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
WO2003101312A1 (en) | 2002-06-03 | 2003-12-11 | Nmt Medical, Inc. | Device with biological tissue scaffold for intracardiac defect closure |
US7431729B2 (en) | 2002-06-05 | 2008-10-07 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US20040044364A1 (en) * | 2002-08-29 | 2004-03-04 | Devries Robert | Tissue fasteners and related deployment systems and methods |
EP1556117A1 (en) | 2002-10-25 | 2005-07-27 | NMT Medical, Inc. | Expandable sheath tubing |
ES2626981T3 (en) | 2002-12-09 | 2017-07-26 | W.L. Gore & Associates, Inc. | Septal closure device |
WO2004069055A2 (en) * | 2003-02-04 | 2004-08-19 | Ev3 Sunnyvale Inc. | Patent foramen ovale closure system |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US20040176788A1 (en) * | 2003-03-07 | 2004-09-09 | Nmt Medical, Inc. | Vacuum attachment system |
US7658747B2 (en) | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
US7473266B2 (en) | 2003-03-14 | 2009-01-06 | Nmt Medical, Inc. | Collet-based delivery system |
US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
US7597704B2 (en) * | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
CN1852688A (en) | 2003-05-19 | 2006-10-25 | 斯托特药物集团公司 | Tissue distention device and related methods for therapeutic intervention |
WO2005006990A2 (en) | 2003-07-14 | 2005-01-27 | Nmt Medical, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US7735493B2 (en) * | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
DE602004017750D1 (en) | 2003-08-19 | 2008-12-24 | Nmt Medical Inc | Expandable lock hose |
JP2007504885A (en) | 2003-09-11 | 2007-03-08 | エヌエムティー メディカル, インコーポレイティッド | Devices, systems and methods for suturing tissue |
US7473260B2 (en) * | 2003-09-11 | 2009-01-06 | Nmt Medical, Inc. | Suture sever tube |
EP1867287B8 (en) * | 2003-10-24 | 2011-10-05 | Tyco Healthcare Group LP | Patent foramen ovale closure system |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
JP4496223B2 (en) | 2003-11-06 | 2010-07-07 | エヌエムティー メディカル, インコーポレイティッド | Septal penetration device |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US7988690B2 (en) | 2004-01-30 | 2011-08-02 | W.L. Gore & Associates, Inc. | Welding systems useful for closure of cardiac openings |
US20050192626A1 (en) | 2004-01-30 | 2005-09-01 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
US20050187568A1 (en) * | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
JP2007526087A (en) | 2004-03-03 | 2007-09-13 | エヌエムティー メディカル, インコーポレイティッド | Delivery / recovery system for septal occluder |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US20050267524A1 (en) | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
US7842069B2 (en) * | 2004-05-07 | 2010-11-30 | Nmt Medical, Inc. | Inflatable occluder |
WO2005110240A1 (en) | 2004-05-07 | 2005-11-24 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
US8764848B2 (en) | 2004-09-24 | 2014-07-01 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US20060079736A1 (en) | 2004-10-13 | 2006-04-13 | Sing-Fatt Chin | Method and device for percutaneous left ventricular reconstruction |
US20060241687A1 (en) * | 2005-03-16 | 2006-10-26 | Glaser Erik N | Septal occluder with pivot arms and articulating joints |
US20060217760A1 (en) * | 2005-03-17 | 2006-09-28 | Widomski David R | Multi-strand septal occluder |
EP1868507A1 (en) | 2005-03-18 | 2007-12-26 | NMT Medical, Inc. | Catch member for pfo occluder |
US8372113B2 (en) * | 2005-03-24 | 2013-02-12 | W.L. Gore & Associates, Inc. | Curved arm intracardiac occluder |
JP4951503B2 (en) * | 2005-03-29 | 2012-06-13 | テルモ株式会社 | Defect closure device |
US7321798B2 (en) * | 2005-03-31 | 2008-01-22 | Medtronic, Inc. | Trans-septal/trans-myocardial ventricular pacing lead |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US8506474B2 (en) | 2005-08-19 | 2013-08-13 | Bioventrix, Inc. | Method and device for treating dysfunctional cardiac tissue |
WO2007022519A2 (en) | 2005-08-19 | 2007-02-22 | Chf Technologies, Inc. | Steerable heart implants for congestive heart failure |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US7797056B2 (en) | 2005-09-06 | 2010-09-14 | Nmt Medical, Inc. | Removable intracardiac RF device |
US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
US20070123934A1 (en) * | 2005-09-26 | 2007-05-31 | Whisenant Brian K | Delivery system for patent foramen ovale closure device |
US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
US9034006B2 (en) * | 2005-12-01 | 2015-05-19 | Atritech, Inc. | Method and apparatus for retrieving an embolized implant |
WO2007073566A1 (en) | 2005-12-22 | 2007-06-28 | Nmt Medical, Inc. | Catch members for occluder devices |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
WO2007115125A2 (en) | 2006-03-31 | 2007-10-11 | Nmt Medical, Inc. | Deformable flap catch mechanism for occluder device |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US9220487B2 (en) | 2006-08-09 | 2015-12-29 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
NZ574737A (en) * | 2006-08-09 | 2012-05-25 | Coherex Medical Inc | Planar or flat devices for reducing the size of an internal tissue opening |
US20080039743A1 (en) * | 2006-08-09 | 2008-02-14 | Coherex Medical, Inc. | Methods for determining characteristics of an internal tissue opening |
US20090270840A1 (en) * | 2008-03-28 | 2009-10-29 | Coherex Medical, Inc. | Delivery systems for a medical device and related methods |
US8529597B2 (en) | 2006-08-09 | 2013-09-10 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US8992545B2 (en) * | 2006-09-28 | 2015-03-31 | W.L. Gore & Associates, Inc. | Implant-catheter attachment mechanism using snare and method of use |
US9211115B2 (en) | 2006-09-28 | 2015-12-15 | Bioventrix, Inc. | Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states |
US7901444B2 (en) * | 2006-09-29 | 2011-03-08 | Codman & Shurtleff, Inc. | Embolic coil delivery system with mechanical release mechanism |
US8029532B2 (en) * | 2006-10-11 | 2011-10-04 | Cook Medical Technologies Llc | Closure device with biomaterial patches |
US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
WO2008094706A2 (en) | 2007-02-01 | 2008-08-07 | Cook Incorporated | Closure device and method of closing a bodily opening |
US8617205B2 (en) | 2007-02-01 | 2013-12-31 | Cook Medical Technologies Llc | Closure device |
US20080228200A1 (en) * | 2007-03-16 | 2008-09-18 | Clinton Baird | Closure and reconstruction implants and the apparatus for delivery thereof |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
WO2008131167A1 (en) | 2007-04-18 | 2008-10-30 | Nmt Medical, Inc. | Flexible catheter system |
US8915958B2 (en) * | 2007-06-08 | 2014-12-23 | St. Jude Medical, Inc. | Devices for transcatheter prosthetic heart valve implantation and access closure |
WO2009011751A1 (en) | 2007-07-13 | 2009-01-22 | Rex Medical, Lp | Vascular hole closure device |
US8025495B2 (en) | 2007-08-27 | 2011-09-27 | Cook Medical Technologies Llc | Apparatus and method for making a spider occlusion device |
US8308752B2 (en) | 2007-08-27 | 2012-11-13 | Cook Medical Technologies Llc | Barrel occlusion device |
US8734483B2 (en) | 2007-08-27 | 2014-05-27 | Cook Medical Technologies Llc | Spider PFO closure device |
US8491455B2 (en) | 2007-10-03 | 2013-07-23 | Bioventrix, Inc. | Treating dysfunctional cardiac tissue |
US20090156986A1 (en) * | 2007-12-12 | 2009-06-18 | Rockford Orthopaedic Sports Medicine Services, Llc | Rotator cuff patch delivery device |
US8920462B2 (en) * | 2008-02-15 | 2014-12-30 | Rex Medical, L.P. | Vascular hole closure device |
US8491629B2 (en) | 2008-02-15 | 2013-07-23 | Rex Medical | Vascular hole closure delivery device |
US20110029013A1 (en) | 2008-02-15 | 2011-02-03 | Mcguckin James F | Vascular Hole Closure Device |
US9226738B2 (en) * | 2008-02-15 | 2016-01-05 | Rex Medical, L.P. | Vascular hole closure delivery device |
US8920463B2 (en) | 2008-02-15 | 2014-12-30 | Rex Medical, L.P. | Vascular hole closure device |
US8070772B2 (en) | 2008-02-15 | 2011-12-06 | Rex Medical, L.P. | Vascular hole closure device |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
DE102008015781B4 (en) * | 2008-03-26 | 2011-09-29 | Malte Neuss | Device for sealing defects in the vascular system |
US8029534B2 (en) | 2009-03-16 | 2011-10-04 | Cook Medical Technologies Llc | Closure device with string retractable umbrella |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9757107B2 (en) | 2009-09-04 | 2017-09-12 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
US9649211B2 (en) | 2009-11-04 | 2017-05-16 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US10092427B2 (en) | 2009-11-04 | 2018-10-09 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
SG183140A1 (en) * | 2010-02-05 | 2012-09-27 | Univ Nanyang Tech | Occlusion device for closing anatomical defects |
WO2012051489A2 (en) | 2010-10-15 | 2012-04-19 | Cook Medical Technologies Llc | Occlusion device for blocking fluid flow through bodily passages |
EP2670313B1 (en) | 2011-02-01 | 2016-01-20 | St. Jude Medical, Inc. | Apparatus for heart valve repair |
US10111663B2 (en) * | 2011-02-18 | 2018-10-30 | Ancora Heart, Inc. | Implant retrieval device |
EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
US8821529B2 (en) | 2011-03-25 | 2014-09-02 | Aga Medical Corporation | Device and method for occluding a septal defect |
US10201336B2 (en) | 2011-03-25 | 2019-02-12 | St. Jude Medical, Cardiology Division, Inc. | Device and method for delivering a vascular device |
US9522064B2 (en) | 2011-05-16 | 2016-12-20 | Hlt, Inc. | Inversion delivery device and method for a prosthesis |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
BR112014007686A2 (en) | 2011-09-30 | 2017-04-18 | Bioventrix Inc | method and system for heart treatment within the patient |
WO2013112797A2 (en) | 2012-01-25 | 2013-08-01 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
WO2013112795A1 (en) | 2012-01-25 | 2013-08-01 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
WO2013116617A1 (en) | 2012-02-02 | 2013-08-08 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
EP2811939B8 (en) | 2012-02-10 | 2017-11-15 | CVDevices, LLC | Products made of biological tissues for stents and methods of manufacturing |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
US9254141B2 (en) | 2012-08-02 | 2016-02-09 | St. Jude Medical, Inc. | Apparatus and method for heart valve repair |
US10105219B2 (en) | 2012-08-02 | 2018-10-23 | St. Jude Medical, Cardiology Division, Inc. | Mitral valve leaflet clip |
US9125653B2 (en) | 2012-08-02 | 2015-09-08 | St. Jude Medical, Cardiology Division, Inc. | Flexible nosecone for percutaneous device |
US9662205B2 (en) | 2012-08-02 | 2017-05-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
US9066710B2 (en) | 2012-10-19 | 2015-06-30 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method for heart valve repair |
JP2016501649A (en) * | 2012-12-27 | 2016-01-21 | トランスカテーテル テクノロギース ゲーエムベーハーTranscatheter Technologies Gmbh | Apparatus and set, implant and method for folding or deploying a medical implant with a clamping mechanism |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US20140228937A1 (en) | 2013-02-11 | 2014-08-14 | Joshua Krieger | Expandable Support Frame and Medical Device |
US9642706B2 (en) | 2013-03-11 | 2017-05-09 | St. Jude Medical, Llc | Apparatus and method for heart valve repair |
BR112015029211A2 (en) | 2013-05-24 | 2017-07-25 | Bioventrix Inc | cardiac tissue penetration devices, methods, and systems for treating congestive heart failure and other conditions |
US9561103B2 (en) | 2013-07-17 | 2017-02-07 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
WO2015031839A1 (en) | 2013-08-30 | 2015-03-05 | Bioventrix, Inc. | Heart anchor positioning devices, methods, and systems for treatment of congestive heart failure and other conditions |
WO2015031647A2 (en) | 2013-08-30 | 2015-03-05 | Bioventrix, Inc. | Cardiac tissue anchoring devices, methods, and systems for treatment of congestive heart failure and other conditions |
US10675450B2 (en) | 2014-03-12 | 2020-06-09 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
EP3171786B1 (en) | 2014-07-23 | 2020-05-13 | Corvia Medical, Inc. | Devices for treating heart failure |
CA2963135A1 (en) | 2014-10-13 | 2016-04-21 | Hlt, Inc. | Inversion delivery device and method for a prosthesis |
EP3229736B1 (en) | 2014-12-09 | 2024-01-10 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and method of manufacture |
GB2534194B (en) | 2015-01-16 | 2017-02-08 | Cook Medical Technologies Llc | Cone Expanding Collapsible Medical Device |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
AU2016262564B2 (en) | 2015-05-14 | 2020-11-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10206779B2 (en) | 2015-09-10 | 2019-02-19 | Bioventrix, Inc. | Systems and methods for deploying a cardiac anchor |
EP3407802B1 (en) | 2016-01-29 | 2024-01-10 | Bioventrix, Inc. | Percutaneous arterial access to position transmyocardial implant devices |
EP3458136B1 (en) * | 2016-05-16 | 2022-08-03 | Valve Medical Ltd. | Inverting temporary valve sheath |
US11331187B2 (en) | 2016-06-17 | 2022-05-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
CR20190381A (en) | 2017-01-23 | 2019-09-27 | Cephea Valve Tech Inc | Replacement mitral valves |
AU2018203053B2 (en) | 2017-01-23 | 2020-03-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
EP3614933A1 (en) | 2017-04-27 | 2020-03-04 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
JP7013591B2 (en) | 2017-12-18 | 2022-01-31 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Closure device with expandable members |
WO2019144072A1 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Occlusive medical device with delivery system |
WO2019213274A1 (en) | 2018-05-02 | 2019-11-07 | Boston Scientific Scimed, Inc. | Occlusive sealing sensor system |
US11241239B2 (en) | 2018-05-15 | 2022-02-08 | Boston Scientific Scimed, Inc. | Occlusive medical device with charged polymer coating |
EP3801301A1 (en) | 2018-06-08 | 2021-04-14 | Boston Scientific Scimed Inc. | Occlusive device with actuatable fixation members |
WO2019237004A1 (en) | 2018-06-08 | 2019-12-12 | Boston Scientific Scimed, Inc. | Medical device with occlusive member |
WO2020010201A1 (en) | 2018-07-06 | 2020-01-09 | Boston Scientific Scimed, Inc. | Occlusive medical device |
WO2020041437A1 (en) | 2018-08-21 | 2020-02-27 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
US11504105B2 (en) | 2019-01-25 | 2022-11-22 | Rex Medical L.P. | Vascular hole closure device |
EP3998962A1 (en) | 2019-07-17 | 2022-05-25 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with continuous covering |
CN114340516A (en) | 2019-08-30 | 2022-04-12 | 波士顿科学医学有限公司 | Left atrial appendage implant with sealing disk |
WO2021195085A1 (en) | 2020-03-24 | 2021-09-30 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
US20230085611A1 (en) * | 2021-09-16 | 2023-03-16 | TAVR Solutions, LLC | Transcatheter atrial septal closure device |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5578045A (en) * | 1992-01-21 | 1996-11-26 | Regents Of The University Of Minnesota | Septal defect closure device |
US5662683A (en) * | 1995-08-22 | 1997-09-02 | Ortho Helix Limited | Open helical organic tissue anchor and method of facilitating healing |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6485504B1 (en) * | 2000-06-22 | 2002-11-26 | James A. Magovern | Hard or soft tissue closure |
US6702835B2 (en) * | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20040092973A1 (en) * | 2002-09-23 | 2004-05-13 | Nmt Medical, Inc. | Septal puncture device |
US20050059984A1 (en) * | 2003-09-11 | 2005-03-17 | Andrzej Chanduszko | Devices, systems, and methods for suturing tissue |
US20080195123A1 (en) * | 1999-09-07 | 2008-08-14 | Ev3, Inc. | Retrievable septal defect closure device |
US7582103B2 (en) * | 2001-08-01 | 2009-09-01 | Ev3 Endovascular, Inc. | Tissue opening occluder |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US98121A (en) * | 1869-12-21 | Improved machine for scouring, setting- out, and finishing hides or skins | ||
US3124136A (en) | 1964-03-10 | Method of repairing body tissue | ||
US92973A (en) * | 1869-07-27 | Improvement in harness-buckle | ||
US579219A (en) * | 1897-03-23 | Ing andharby c | ||
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4007743A (en) | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
FR2606641B1 (en) * | 1986-11-17 | 1991-07-12 | Promed | FILTERING DEVICE FOR BLOOD CLOTS |
US4836204A (en) | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US4917089A (en) | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
FR2641692A1 (en) | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US6190400B1 (en) | 1991-10-22 | 2001-02-20 | Kensey Nash Corporation | Blood vessel sealing device and method of sealing an opening in a blood vessel |
US5021059A (en) | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US5108420A (en) | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5254133A (en) | 1991-04-24 | 1993-10-19 | Seid Arnold S | Surgical implantation device and related method of use |
CA2078530A1 (en) | 1991-09-23 | 1993-03-24 | Jay Erlebacher | Percutaneous arterial puncture seal device and insertion tool therefore |
DE69229539T2 (en) | 1991-11-05 | 2000-02-17 | Childrens Medical Center | Occlusion device for repairing heart and vascular defects |
DE69226841T2 (en) | 1991-11-05 | 1999-05-20 | Childrens Medical Center | Occlusion device for repairing heart and vascular defects |
DK168419B1 (en) | 1991-11-25 | 1994-03-28 | Cook Inc A Cook Group Company | Abdominal wall support device and apparatus for insertion thereof |
US5258000A (en) | 1991-11-25 | 1993-11-02 | Cook Incorporated | Tissue aperture repair device |
US5486193A (en) | 1992-01-22 | 1996-01-23 | C. R. Bard, Inc. | System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder |
US5231561A (en) * | 1992-02-18 | 1993-07-27 | Motorola, Inc. | Mounting method and apparatus for PWA shielding |
US5342393A (en) | 1992-08-27 | 1994-08-30 | Duke University | Method and device for vascular repair |
US5643317A (en) | 1992-11-25 | 1997-07-01 | William Cook Europe S.A. | Closure prosthesis for transcatheter placement |
US5284488A (en) | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5356432B1 (en) | 1993-02-05 | 1997-02-04 | Bard Inc C R | Implantable mesh prosthesis and method for repairing muscle or tissue wall defects |
US6346074B1 (en) | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
WO1995008289A2 (en) | 1993-09-16 | 1995-03-30 | Scimed Life Systems, Inc. | Percutaneous repair of cardiovascular anomalies and repair compositions |
WO1995010328A1 (en) | 1993-10-12 | 1995-04-20 | Scimed Life Systems, Inc. | Apparatus and method for tissue defect repair |
JP3185906B2 (en) | 1993-11-26 | 2001-07-11 | ニプロ株式会社 | Prosthesis for atrial septal defect |
WO1998020939A2 (en) | 1996-11-15 | 1998-05-22 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
US5846261A (en) | 1994-07-08 | 1998-12-08 | Aga Medical Corp. | Percutaneous catheter directed occlusion devices |
US6123715A (en) | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5433727A (en) | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US6110212A (en) | 1994-11-15 | 2000-08-29 | Kenton W. Gregory | Elastin and elastin-based materials |
US6087552A (en) | 1994-11-15 | 2000-07-11 | Sisters Of Providence Of Oregon | Method of producing fused biomaterials and tissue |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5634936A (en) * | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US6117144A (en) | 1995-08-24 | 2000-09-12 | Sutura, Inc. | Suturing device and method for sealing an opening in a blood vessel or other biological structure |
DE69612507T2 (en) | 1995-10-30 | 2001-08-09 | Childrens Medical Center | SELF-CENTERING, SHIELD-LIKE DEVICE FOR CLOSING A SEPTAL DEFECT |
DE19604817C2 (en) * | 1996-02-09 | 2003-06-12 | Pfm Prod Fuer Die Med Ag | Device for closing defect openings in the human or animal body |
US5871537A (en) | 1996-02-13 | 1999-02-16 | Scimed Life Systems, Inc. | Endovascular apparatus |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5853422A (en) | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US5662681A (en) * | 1996-04-23 | 1997-09-02 | Kensey Nash Corporation | Self locking closure for sealing percutaneous punctures |
WO1997041778A1 (en) | 1996-05-08 | 1997-11-13 | Salviac Limited | An occluder device |
US5792179A (en) | 1996-07-16 | 1998-08-11 | Sideris; Eleftherios B. | Retrievable cardiac balloon placement |
US5741297A (en) | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5861003A (en) | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US6096052A (en) | 1998-07-08 | 2000-08-01 | Ovion, Inc. | Occluding device and method of use |
US5944750A (en) * | 1997-06-30 | 1999-08-31 | Eva Corporation | Method and apparatus for the surgical repair of aneurysms |
US6174322B1 (en) * | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US5976174A (en) | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
US6280460B1 (en) | 1998-02-13 | 2001-08-28 | Heartport, Inc. | Devices and methods for performing vascular anastomosis |
JP3799810B2 (en) * | 1998-03-30 | 2006-07-19 | ニプロ株式会社 | Transcatheter surgery closure plug and catheter assembly |
JP3733580B2 (en) | 1998-04-06 | 2006-01-11 | ニプロ株式会社 | Closure collection tool for defect closure |
WO1999062431A1 (en) | 1998-06-02 | 1999-12-09 | Cook Incorporated | Multiple-sided intraluminal medical device |
US6210338B1 (en) | 1998-08-21 | 2001-04-03 | Aga Medical Corp. | Sizing catheter for measuring cardiovascular structures |
US5919200A (en) | 1998-10-09 | 1999-07-06 | Hearten Medical, Inc. | Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter |
US7128073B1 (en) * | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US6152144A (en) * | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US6238416B1 (en) | 1998-11-13 | 2001-05-29 | Eleftherios B. Sideris | Transcatheter surgical patch |
US6156055A (en) | 1999-03-23 | 2000-12-05 | Nitinol Medical Technologies Inc. | Gripping device for implanting, repositioning or extracting an object within a body vessel |
JP2000300571A (en) * | 1999-04-19 | 2000-10-31 | Nissho Corp | Closure plug for transcatheter operation |
US6206907B1 (en) | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6319283B1 (en) * | 1999-07-02 | 2001-11-20 | Bristol-Myers Squibb Company | Tibial knee component with a mobile bearing |
US6596014B2 (en) | 1999-07-13 | 2003-07-22 | Scion Cardio-Vascular, Inc. | Suture with toggle and method of manufacture therefor |
US6206895B1 (en) * | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6598014B1 (en) * | 1999-10-21 | 2003-07-22 | Massachusetts Institute Of Technology | Closed-loop multistage beamformer |
AU1233301A (en) * | 1999-10-26 | 2001-05-08 | H. Randall Craig | Helical suture instrument |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6391048B1 (en) | 2000-01-05 | 2002-05-21 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
US6197042B1 (en) | 2000-01-05 | 2001-03-06 | Medical Technology Group, Inc. | Vascular sheath with puncture site closure apparatus and methods of use |
US6461364B1 (en) | 2000-01-05 | 2002-10-08 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
US6468303B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Retrievable self expanding shunt |
US6551344B2 (en) * | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
US6440152B1 (en) * | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US6645225B1 (en) * | 2000-11-01 | 2003-11-11 | Alvan W. Atkinson | Method and apparatus for plugging a patent foramen ovale formed in the heart |
US6776784B2 (en) * | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
EP1467661A4 (en) * | 2001-12-19 | 2008-11-05 | Nmt Medical Inc | Septal occluder and associated methods |
AU2003210510A1 (en) * | 2002-01-14 | 2003-07-30 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure method and device |
AU2003220502A1 (en) * | 2002-03-25 | 2003-10-13 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
US7431729B2 (en) * | 2002-06-05 | 2008-10-07 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
WO2004069055A2 (en) * | 2003-02-04 | 2004-08-19 | Ev3 Sunnyvale Inc. | Patent foramen ovale closure system |
US8021359B2 (en) * | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
WO2004087235A2 (en) * | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
EP1867287B8 (en) * | 2003-10-24 | 2011-10-05 | Tyco Healthcare Group LP | Patent foramen ovale closure system |
US20050192626A1 (en) * | 2004-01-30 | 2005-09-01 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
US20050187568A1 (en) * | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
-
2000
- 2000-07-28 US US09/628,211 patent/US6440152B1/en not_active Expired - Lifetime
-
2001
- 2001-07-20 CA CA002353333A patent/CA2353333A1/en not_active Abandoned
- 2001-07-25 EP EP09013604A patent/EP2158847A1/en not_active Withdrawn
- 2001-07-25 ES ES01402011T patent/ES2343401T3/en not_active Expired - Lifetime
- 2001-07-25 EP EP01402011A patent/EP1175867B1/en not_active Expired - Lifetime
- 2001-07-25 DE DE60140782T patent/DE60140782D1/en not_active Expired - Lifetime
- 2001-07-27 JP JP2001228186A patent/JP2002119515A/en active Pending
-
2002
- 2002-08-26 US US10/227,773 patent/US7479155B2/en not_active Expired - Fee Related
-
2009
- 2009-01-20 US US12/356,506 patent/US20090131978A1/en not_active Abandoned
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5578045A (en) * | 1992-01-21 | 1996-11-26 | Regents Of The University Of Minnesota | Septal defect closure device |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US5662683A (en) * | 1995-08-22 | 1997-09-02 | Ortho Helix Limited | Open helical organic tissue anchor and method of facilitating healing |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US20080195123A1 (en) * | 1999-09-07 | 2008-08-14 | Ev3, Inc. | Retrievable septal defect closure device |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6485504B1 (en) * | 2000-06-22 | 2002-11-26 | James A. Magovern | Hard or soft tissue closure |
US7582103B2 (en) * | 2001-08-01 | 2009-09-01 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US6702835B2 (en) * | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20040092973A1 (en) * | 2002-09-23 | 2004-05-13 | Nmt Medical, Inc. | Septal puncture device |
US20050059984A1 (en) * | 2003-09-11 | 2005-03-17 | Andrzej Chanduszko | Devices, systems, and methods for suturing tissue |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10292690B2 (en) | 2006-11-07 | 2019-05-21 | Corvia Medical, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US8740962B2 (en) | 2006-11-07 | 2014-06-03 | Dc Devices, Inc. | Prosthesis for retrieval and deployment |
US8745845B2 (en) | 2006-11-07 | 2014-06-10 | Dc Devices, Inc. | Methods for mounting a prosthesis onto a delivery device |
US8752258B2 (en) | 2006-11-07 | 2014-06-17 | Dc Devices, Inc. | Mounting tool for loading a prosthesis |
US8882697B2 (en) | 2006-11-07 | 2014-11-11 | Dc Devices, Inc. | Apparatus and methods to create and maintain an intra-atrial pressure relief opening |
US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
US10045766B2 (en) | 2006-11-07 | 2018-08-14 | Corvia Medical, Inc. | Intra-atrial implants to directionally shunt blood |
US10610210B2 (en) | 2006-11-07 | 2020-04-07 | Corvia Medical, Inc. | Methods for deploying a prosthesis |
US10188375B2 (en) | 2006-11-07 | 2019-01-29 | Corvia Medical, Inc. | Devices, systems, and methods to treat heart failure having an improved flow-control mechanism |
US11166705B2 (en) | 2006-11-07 | 2021-11-09 | Corvia Medical, Inc. | Intra-atrial implants made of non-braided material |
US9358371B2 (en) | 2006-11-07 | 2016-06-07 | Corvia Medical, Inc. | Intra-atrial implants made of non-braided material |
US10413286B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Intra-atrial implants having variable thicknesses to accommodate variable thickness in septum |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
US9456812B2 (en) | 2006-11-07 | 2016-10-04 | Corvia Medical, Inc. | Devices for retrieving a prosthesis |
US20110071623A1 (en) * | 2006-11-07 | 2011-03-24 | Dc Devices, Inc. | Methods for deploying a prosthesis |
US9277995B2 (en) | 2010-01-29 | 2016-03-08 | Corvia Medical, Inc. | Devices and methods for reducing venous pressure |
US8951223B2 (en) | 2011-12-22 | 2015-02-10 | Dc Devices, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
US9642993B2 (en) | 2011-12-22 | 2017-05-09 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having selectable flow rates |
US9205236B2 (en) | 2011-12-22 | 2015-12-08 | Corvia Medical, Inc. | Methods, systems, and devices for resizable intra-atrial shunts |
US9005155B2 (en) | 2012-02-03 | 2015-04-14 | Dc Devices, Inc. | Devices and methods for treating heart failure |
US10588611B2 (en) | 2012-04-19 | 2020-03-17 | Corvia Medical Inc. | Implant retention attachment and method of use |
US9649480B2 (en) | 2012-07-06 | 2017-05-16 | Corvia Medical, Inc. | Devices and methods of treating or ameliorating diastolic heart failure through pulmonary valve intervention |
US9775636B2 (en) | 2013-03-12 | 2017-10-03 | Corvia Medical, Inc. | Devices, systems, and methods for treating heart failure |
Also Published As
Publication number | Publication date |
---|---|
US20020198563A1 (en) | 2002-12-26 |
EP1175867A2 (en) | 2002-01-30 |
CA2353333A1 (en) | 2002-01-28 |
JP2002119515A (en) | 2002-04-23 |
ES2343401T3 (en) | 2010-07-30 |
EP2158847A1 (en) | 2010-03-03 |
US6440152B1 (en) | 2002-08-27 |
US7479155B2 (en) | 2009-01-20 |
DE60140782D1 (en) | 2010-01-28 |
EP1175867A3 (en) | 2003-10-29 |
EP1175867B1 (en) | 2009-12-16 |
EP2158847A8 (en) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7479155B2 (en) | Defect occluder release assembly and method | |
US8029534B2 (en) | Closure device with string retractable umbrella | |
EP1392176B1 (en) | Closure devices and tools | |
JP5507838B2 (en) | Percutaneous catheter for endovascular occlusion devices | |
EP1867287B1 (en) | Patent foramen ovale closure system | |
EP0947165B1 (en) | Vascular closure device and catheter | |
US6913614B2 (en) | Delivery system with safety tether | |
US20070123934A1 (en) | Delivery system for patent foramen ovale closure device | |
US20140371789A1 (en) | Minimally invasive surgical techniques | |
JP2016202905A (en) | Medical device for modification of left atrial appendage and related systems and methods | |
US20120065673A1 (en) | Septal defect closure device | |
JP2008512139A (en) | Closing device, method of supplying the closing device, and method of using the closing device | |
EP0623003A1 (en) | Septal defect closure device | |
US20210186515A1 (en) | Method And System For Closure Of Cardiovascular Apertures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EV3 ENDOVASCULAR, INC.,MINNESOTA Free format text: CHANGE OF NAME;ASSIGNOR:EV3 INC.;REEL/FRAME:023917/0001 Effective date: 20050131 Owner name: EV3 INC.,MINNESOTA Free format text: MERGER;ASSIGNOR:MICROVENA CORPORATION;REEL/FRAME:023917/0137 Effective date: 20020903 Owner name: MICROVENA CORPORATION,MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GAINOR, JOHN P.;DUKART, BRIAN L.;WEGNER, DARREN L.;SIGNING DATES FROM 20001107 TO 20001109;REEL/FRAME:023917/0652 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |